Search bioRxiv⌕ Search

Biology subjects

Gangolli, M.

Publications and source records attributed to Gangolli, M..

2 recordsLinked to original sources

SEQUIN multiscale imaging of mammalian central synapses reveals loss of synaptic microconnectivity resulting from diffuse traumatic brain injury

The complex microconnectivity of the mammalian brain underlies its computational abilities, and its vulnerability to injury and disease. It has been challenging to illuminate the features of this synaptic network due in part to the small size and exceptionally dense packing of its elements. Here we describe a rapid and accessible super-resolution imaging and image analysis workflow--SEQUIN--that identifies, quantifies, and characterizes central synapses in animal models and in humans, enabling automated volumetric imaging of mesoscale synaptic networks without the laborious production of large histological arrays. Using SEQUIN, we identify delayed cortical synapse loss resulting from diffuse traumatic brain injury. Similar synapse loss is observed in an Alzheimer disease model, where SEQUIN mesoscale mapping of excitatory synapses across the hippocampus identifies region-specific synaptic vulnerability to neurodegeneration. These results establish a novel, easily implemented and robust nano-to-mesoscale synapse quantification and molecular characterization method. They furthermore identify a mechanistic link--synaptopathy--between Alzheimer neurodegeneration and its best-established epigenetic risk factor, brain trauma.

neuroscience↗

Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls

An unanswered question regarding Alzheimer disease dementia (ADD) is whether amyloid-beta (A{beta}) plaques sequester toxic soluble A{beta} species early in the pathological progression. We previously reported that the concentration of soluble A{beta} aggregates from patients with mild dementia was higher than soluble A{beta} aggregates from patients with modest A{beta} plaque burden but no dementia. The ratio of soluble A{beta} aggregate concentration to A{beta} plaque area fully distinguished these groups of patients. We hypothesized that initially plaques may serve as a reservoir or sink for toxic soluble A{beta} aggregates, sequestering them from other targets in the extracellular space and thereby preventing their toxicity. To initially test a generalized version of this hypothesis, we have performed binding assessments using biotinylated synthetic A{beta}1-42 peptide. A{beta}1-42-biotin peptide was incubated on unfixed frozen sections from non-demented high plaque pathology controls and patients with dementia of the Alzheimer type. The bound peptide was measured using ELISA and confocal microscopy. We observed no quantitative difference in A{beta} binding between the groups using either method. Further testing of the buffering hypothesis using various forms of synthetic and human derived soluble A{beta} aggregates will be required to definitively address the role of plaque buffering as it relates to ADD.

neuroscience↗